IRCT2014102619678N1已完成1 期
Efficacy of fluoroquinolones in treating interferon non-responders infected with HCV genotype 3a
Higher Education Commission, Pakistan0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 years 至 60 years（—）
- 性别
- All
入选标准
- •Patient on IFN treatment who have not shown two-log reduction in their HCV load for 3 months
- •HCV-RNA positive
- •Infection with HCV genotype 3a
- •Chronic hepatitis diagnosed by liver ultrasound
- •Pre-cirrhotic, as determined by liver ultrasound
- •Informed consent to participate in the study
- •Exclusion criteria:
- •Known hypersensitivity to fluoroquinolones
- •Infection with HCV genotype other than 3a
- •Pregnant females
- •Concurrent hepatitis B or HIV infection
- •Carcinomatous changes on liver biopsy evident in liver ultrasound
- •History of alcohol or intravenous drug abuse
- •Disinclination to informed consent
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritisJPRN-UMIN000003897Department of Infectious Diseases and Infection Control, Jikei University School of Medicine20
进行中（未招募）
1 期
Pharmacokinetic evaluation of fluoroquinolone antibiotics administered intravenously in intensive care patients with normal renal function and with renal hyperfiltratioIntensive care patientsEUCTR2010-019691-70-BEGhent University
已完成
不适用
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus BacteremiaStaphylococcus AureusSepsisBacteremiaEndocarditisNCT00548002University of Helsinki430
已完成
不适用
FQ Restriction for the Prevention of CDIClostridium DifficileClostridium Difficile InfectionC Difficile ColitisNCT03848689University of Wisconsin, Madison5,871
已完成
不适用
Feasibility and efficacy of FOLFIRINOX therapy in patients with borderline resectable pancreatic cancer in the neoadjvant setting.Borderline resectable pancreatic cancerJPRN-UMIN000034509Department of Hepatobiliary Pancreatic Surgery, Saitama Medical Center, Saitama Medical University30